“Action Replay” – the German Federal Supreme Court submits questions on copyright protection against “cheating” devices for PlayStation Portable games to the European Court of Justice

Written By

christoph hendel module
Dr. Christoph Hendel

Counsel
Germany

I am an associate in our commercial team in Düsseldorf where I specialise in copyright, media, unfair competition and advertising law, advising our clients in the media and entertainment industries as well as in the consumer products and healthcare sectors.

niels lutzhoeft Module
Dr. Niels Lutzhöft, LL.M.

Partner
Germany

I am a strategic advisor and litigator for life science and digital media companies – stepping in at the crossroads of IP and sector regulation.

In a legal dispute that has been ongoing for more than 10 years between Sony and the manufacturers and distributors of the “Action Replay” hacking devices, the German Federal Supreme Court has now referred two questions to the Court of Justice of the European Union (“CJEU”) concerning the scope of copyright protection for computer programs[1]: 1) Is variable data in random access memory part of a computer program protected under copyright law? 2) Does the modification of such data by other software constitute an unauthorised alteration of this computer program? There are substantial arguments for and against copyright protection. The Federal Supreme Court appears to favor a narrow construction of the relevant provisions, thereby limiting the extent of the author’s right of alteration of the original code. However, the CJEU may also draw on substantial arguments supporting a broader, more technology-neutral understanding of the law.

Latest insights

More Insights
featured image

Germany: The insured event in the automotive product recall cost insurance

5 minutes Jul 03 2025

Read More
Curiosity line teal background

Restructuring - Australian Retail & Hospitality Series: Part 2 - Creative Restructuring Approaches: What’s Working in Retail & Hospitality Administrations

Jul 03 2025

Read More
featured image

EPO Upholds, UPC Revokes: A Tale of Diverging Views on PCSK9 Antibody Patent

2 minutes Jul 02 2025

Read More